Harm reduction-focused behavioral activation for people who inject drugs: Mixed methods outcomes from a pilot open trial.

Autor: Paquette C; Duke University School of Medicine Department of Population Health Sciences, Durham, North Carolina, United States; University of North Carolina at Chapel Hill, United States. Electronic address: catherine.paquette@duke.edu., Vierling A; University of North Carolina at Chapel Hill, United States., Kane L; University of North Carolina at Chapel Hill, United States., Abrego PL; University of North Carolina at Chapel Hill, United States., Benson K; University of North Carolina at Chapel Hill, United States., Jordan E; East Carolina University, United States., Baucom D; University of North Carolina at Chapel Hill, United States., Zule W; RTI International, United States., Daughters S; University of North Carolina at Chapel Hill, United States.
Jazyk: angličtina
Zdroj: Journal of substance use and addiction treatment [J Subst Use Addict Treat] 2024 Dec; Vol. 167, pp. 209490. Date of Electronic Publication: 2024 Aug 22.
DOI: 10.1016/j.josat.2024.209490
Abstrakt: Introduction: People who inject drugs (PWID) experience high rates of mental health problems and drug-related harms. Harm reduction-focused interventions aim to reduce harms associated with drug use and are an important approach for engaging people who are not seeking traditional abstinence-focused treatment. Yet, few studies to date have examined the effectiveness of harm reduction psychosocial treatment for drug use. We evaluated the outcomes of a harm reduction-focused behavioral activation (BA) intervention from pretreatment to a 1-month follow-up.
Methods: A total of N = 23 PWID (65.2 % White; 52.2 % women; mean age 35.4 ± 7.8 years) were recruited from syringe services programs and n = 19 received the intervention via teletherapy. Assessment of study outcome measures occurred at pre- and posttreatment and a one-month follow-up.
Results: Results reflected post-intervention increases in behavioral activation and readiness to change drug use, as well as decreases in substance use, depression, and HIV risk behaviors. There were mixed outcomes on substance-related problems with increases at follow-up, possibly reflecting increased problem recognition.
Conclusions: These results suggest initial promise for the harm reduction-focused treatment. Additional research with randomized designs and larger sample sizes is needed, and more intensive treatment may be required to support sustained treatment gains in this population.
Competing Interests: Declaration of competing interest The first author was an unpaid direct service volunteer with the North Carolina Harm Reduction Coalition, which was a partner in this research, during the study period; she now serves on the Board of Directors in an unpaid volunteer role. The authors have no other competing interests to declare.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: